Michael P. Simpson Joins Small Bone Innovations as President and CEO

Anthony G. Viscogliosi named Executive Chairman

Michael P. Simpson is the new President & CEO of Small Bone Innovations Inc., the privately-held orthopedic device company. Simpson was formerly a division president at OrthoFix (Nasdaq:OFIX)(Photo: Business Wire)

???news_view.multimedia.download???

Michael P. Simpson is the new President & CEO of Small Bone Innovations Inc., the privately-held orthopedic device company. Simpson was formerly a division president at OrthoFix (Nasdaq:OFIX)(Photo: Business Wire)

NEW YORK--(BUSINESS WIRE)--Small Bone Innovations, Inc. (SBi), a leading, privately held
orthopedics company focused exclusively on arthroplasty and
joint-related trauma technologies and treatments for the small bones and
joints, has appointed Michael P. Simpson as President and Chief
Executive Officer, effective February 21, 2012.

Mr. Simpson’s appointment enables Anthony G. Viscogliosi, SBi’s Founder,
Chairman and CEO since 2005, to step up to the new position of Executive
Chairman. Mr. Simpson held several senior executive positions during his
nine year career at Orthofix, Inc., a unit of Orthofix International NV
(NASDAQ: OFIX).

Mr. Viscogliosi said: “SBi’s revenues, excluding discontinued products,
have been growing at a compound average annual growth rate of 27 percent
during the period 2006-2011, achieving critical mass in terms of balance
sheet, revenues, product portfolio and a distribution network serving 41
countries. Having established and secured this platform for continuing
growth and profitability, SBi’s Board of Directors and I decided that we
had reached the point where an executive seasoned in growing a critical
mass platform into a larger scale business should now be recruited as
our CEO with a mission to ensure continued growth by leveraging our
portfolio of market leading products.”

“Michael P. Simpson is a great choice to seize this opportunity, based
on his track record at Orthofix. He is a deeply experienced professional
in the orthopedics industry who understands the extremities implant
market and the demand for evidence-based medicine in terms of pain
elimination and joint preservation,” he added.

During Mr. Simpson’s career as a division President at Orthofix, an
orthopedic devices company with $575 million-plus revenues in 2011, he
managed the global development and distribution internationally of the
product portfolio, including foot and ankle technologies, with full P&L
responsibility.

Mr. Simpson will report to the Executive Chairman and the SBi Board of
Directors, and become a member of both SBi’s Operating and Executive
Committees. As President and CEO, all officers of the company will
report to him in support of his primary task of generating continued
success and profitability from SBi’s global sales and operations.

“SBi has an enviable record of essentially redefining the small bone and
joint sector by introducing innovative arthroplasty and joint-related
trauma technologies such as the market leading STAR™ Total Ankle
Replacement and the line of RingFIX™ lower limb products designed to
treat patients with diabetic foot complications. This unique platform
offers an opportunity to leverage my skills and experience to help SBi
extend its penetration of the rapidly growing $3.3 billion small bone
and joint market,” Mr. Simpson said.

Note to editors: Michael P. Simpson is not related to Michael J.
Simpson who served as SBi’s President and COO from 2005 through 2008.
Data on the Small Bone and Joint market estimate for 2011 from
Viscogliosi Brothers, LLC.

About Small Bone Innovations, Inc.

Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi
Brothers, LLC (VB), the New York-based merchant banking firm that
specializes in the musculoskeletal/orthopedics sector. SBi was the first
company to focus purely on small bones & joints by integrating
established companies and professionals in the field. It offers a broad,
clinically proven portfolio of products and technologies to treat trauma
and diseases in the small bones & joints. SBi has facilities in New
York, NY, Morrisville, PA, Péronnas, France, Donaueschingen, Germany,
and Kuala Lumpur, Malaysia and has sold its products in 41 countries.